Microbiome startup raises $48M for immunotherapy and malnutrition treatments

Kanvas Biosciences' imaging technology applied to a mouse colon allows scientists to detect how genes are expressed by different microbes (Courtesy Kanvas) May 5, 2026 10:30 AM EDT FinancingR&D Ex­clu­sive: One can­cer sur­vivor's su­per poop is be­hind mi­cro­bio­me star­tup's $48M raise Ryan Cross Senior Science Correspondent Sci­en­tists try­ing to un­der­stand why can­cer im­munother­a­py works so well for some pa­tients and not oth­ers have found a po­ten­tial an­swer in one can­cer sur­vivor’s … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER